SUBJECTIVE:
- 56-year-old female presents with complaint of difficulty catching her breath and chest tightness.
- Reports not using albuterol inhaler recently, as she has not felt the need for it.
- Denies current medication use.
- No history of asthma management details provided; unclear duration or frequency of current symptoms.
- No mention of cough, fever, chills, sputum production, chest pain (other than tightness), palpitations, wheezing heard by patient, or edema.
- No history of recent upper respiratory infection or sick contacts.
- No other review of systems concerns reported at this time.
- No known drug allergies.
- Here for annual well visit in addition to acute complaints.

OBJECTIVE:
Vitals: BP: [not available] | HR: [not available] | Temp: [not available] | RR: [not available] | SpO2: [not available]
Physical Exam:
Gen: AAO x 3. NAD.
HEENT: MMM, no lymphadenopathy.
CV: Normal rate, regular rhythm. No m/c/g/r.
Lungs: Normal work of breathing. CTAB with mild expiratory wheezing.
Abd: Normoactive bowel sounds. Soft, non-tender.
Ext: No clubbing, cyanosis, or edema.
Skin: No rashes or lesions.

ASSESSMENT/PLAN:
Chest Tightness, Expiratory Wheezing, Suspected Asthma (R06.4):
- Initiate montelukast 10 mg daily for asthma symptoms.
- Monitor respiratory symptoms closely; instruct patient to resume albuterol inhaler PRN if symptoms worsen.
- Pulmonary function testing to assess airway reactivity and baseline lung function.
- Annual well visit labs as appropriate (CBC, BMP, TSH, lipid panel).
- Patient education on asthma management, inhaler technique, and avoidance of triggers.
- Follow up in 2 weeks or sooner if symptoms worsen.
Annual Preventive Health Evaluation (Z00.00):
- Perform standard age-appropriate screening and health maintenance labs.
- Address any additional preventive care needs at this visit.
- Educate on importance of regular check-ups and monitoring chronic symptoms.

ORDERS:
Medications:
Medication: Montelukast 10 mg tablet 
Sig: Take 1 tablet (10 mg) by mouth once daily in the evening for asthma control. 
Dispense: 30 tablets 
Refills: 2
Labs:
- CBC
- BMP
- TSH
- Lipid panel
Imaging:
- None at this time
Referrals:
- Pulmonary function testing to assess for asthma and airway reactivity
Patient Education:
- Reviewed asthma symptoms, medication indications, inhaler technique, and trigger avoidance. Instructed to resume albuterol as needed and to seek care for worsening symptoms (e.g., severe shortness of breath, chest pain, persistent wheezing).
Follow-up:
- Return to clinic in 2 weeks to review symptoms and test results, or sooner if respiratory symptoms worsen. Annual well visit to continue per preventive health schedule.